Last week, two bearish analysts finally threw in the towel on Tesla, and the stock market has not stopped running. The stock hit another $ 381 this week, up 24%, expanding its 2020 earnings to around 380%. Shares broke the $ 2,000 barrier on Thursday and, of course, rose again …
Read More »Pfizer’s Covid-19 vaccine could be authorized by October, analysts say
Text size Jeenah Moon / Getty Images Pfizer hopes to get emergency food authorization from the Food and Drug Administration for its Covid-19 vaccine, produced in collaboration with BioNTech, in October – a timeline that is possible, and not the only positive for the biotech industry, according to a Mizuho …
Read More »Sanofi Buys Principia for $ 3.7 billion. Both front runs.
Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …
Read More »News updates: McKesson Stock jumps after Trump says company would spread Coronavirus vaccine
(Photo by Joe Raedle / Getty Images) Getty Images Text size Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • President Donald Trump said Friday that McKesson would work with the U.S. government to spread a coronavirus vaccine if one is approved. …
Read More »Novavax stock jumps on vaccinated deal with South Korean firm
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »